As Mylan N V (NASDAQ:MYL) Price Declined, Fil Ltd Upped Position

May 16, 2018 - By Darrel Chase

Mylan N.V. (NASDAQ:MYL) Corporate LogoBig Money Sentiment increased to 3 in Q4 2017. It has change of 2.67, from 2017Q3’s 0.33. The ratio improved due to MYL positioning: 0 sold and 1 reduced. 3 funds amassed positions and 0 increased positions. Investors holded 155,019 in 2017Q3 but now own 292,846 shares or 88.91% more. Van Hulzen Asset Mgmt reported 120,545 shs stake. Vantage Advsrs Ltd Liability Co reported 337 shs. Gulf Intll Savings Bank (Uk) Ltd reported 139,930 shs. 17,231 are owned by Mirae Asset Global Invs Ltd.

Fil Ltd’s holdings in Mylan N V (NASDAQ:MYL) was upped by 6.62% based on its latest 2018Q1 regulatory filling with the SEC. Mylan N V (NASDAQ:MYL) stock Sank 5.99% while Fil Ltd bought 343,102 shares. Fil Ltd’s position was priced at $227.35M for 5.52M shares. It’s up from 5.18 million last quarter. $20.17 billion is the Mylan N V’s MC. MYL is hitting $39.18 during the last trading session, after increased 1.77%.Currently Mylan N.V. is downtrending after 5.23% change in last May 16, 2017. MYL has 3.20M shares volume. MYL underperformed by 16.78% the S&P 500.

According to the regulatory filling Fil Ltd reduced its stake in United Parcel Service Inc (NYSE:UPS) by 264,917 shares to 1.73 million shares, valued at $180.66 million in 2018Q1. The fund has $36.38B US longs. It decreased Davita Inc (NYSE:DVA) position by 602,388 shares to 155,256 shares, and cut its Verisk Analytics Inc (NASDAQ:VRSK) stake.

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

In total 14 analysts cover Mylan Inc (NASDAQ:MYL). “Buy” rating has 11, “Sell” are 0, while 3 are “Hold”. 79% are bullish. 20 are the (NASDAQ:MYL)’s analyst reports since December 4, 2017 according to StockzIntelligence Inc. On Thursday, March 15 the firm earned “Buy” rating by Mizuho. The stock rating was maintained by Cantor Fitzgerald with “Hold” on Thursday, March 1. In Thursday, December 21 report Cantor Fitzgerald maintained it with “Hold” rating and $41.0 target. On Tuesday, December 12 the stock of Mylan N.V. (NASDAQ:MYL) earned “Buy” rating by Guggenheim. On Tuesday, February 6 the rating was maintained by BMO Capital Markets with “Buy”. On Thursday, January 18 the company was maintained by Wells Fargo. The company rating was maintained by Citigroup on Thursday, January 4. On Thursday, January 11 the stock of Mylan N.V. (NASDAQ:MYL) earned “Buy” rating by Goldman Sachs. In Tuesday, March 6 report Morgan Stanley upgraded the stock to “Overweight” rating. On Thursday, April 12 Mizuho maintained Mylan N.V. (NASDAQ:MYL) with “Buy” rating.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide.The company has $20.17 billion market cap. The firm operates through three divisions: North America, Europe, and Rest of World.30.14 is the P/E ratio. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Mylan N.V. (NASDAQ:MYL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: